Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
International Journal of Cardiology
|
May 23, 1997
Incidence and clinical significance of short-term recurrent ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillator
R Fries, A Heisel, H Huwer, et al.
Zeitschrift Fur Kardiologie
|
April 21, 1999
[Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)]
E Himmrich, A Liebrich, U Michel, et al.
European Heart Journal
|
July 4, 1998
Permanent junctional re-entry tachycardia. A multicentre long-term follow-up study in infants, children and young adults
A Lindinger, A Heisel, G von Bernuth, et al.
Zeitschrift Fur Kardiologie
|
February 20, 1999
[Reproducibility of the effectiveness of defibrillation for terminating induced ventricular fibrillation using intraoperatively measured defibrillation threshold energy in patients with implanted cardioverter-defibrillator]
J Jung, J Neuzner, E Himmrich, et al.
Journal of Pediatric Hematology/Oncology
|
July 1, 1997
The use of implantable venous access devices (IVADs) in children with hemophilia
J L Perkins, V A Johnson, J M Osip, et al.
The American Journal of Cardiology
|
March 25, 1999
Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter Low-Energy Endotak Trial
J Neuzner, A Liebrich, J Jung, et al.
The Journal of Pediatrics
|
October 1, 1984
Congenital pernicious anemia: report of seven patients, with studies of the extended family
M A Heisel, S E Siegel, R E Falk, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
September 9, 2018
Long-term symptom improvement and patient satisfaction after AV-node ablation vs. pulmonary vein isolation for symptomatic atrial fibrillation: results from the German Ablation Registry
Kristina Wasmer, M Hochadel, H Wieneke, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
June 28, 2000
Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors
S Arkin, F Blei, J Fetten, et al.
Blood
|
September 24, 2004
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B
Amy D Shapiro, Jorge Di Paola, Alice Cohen, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
International Journal of Cardiology
|
May 23, 1997
Incidence and clinical significance of short-term recurrent ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillator
R Fries, A Heisel, H Huwer, et al.
Zeitschrift Fur Kardiologie
|
April 21, 1999
[Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)]
E Himmrich, A Liebrich, U Michel, et al.
European Heart Journal
|
July 4, 1998
Permanent junctional re-entry tachycardia. A multicentre long-term follow-up study in infants, children and young adults
A Lindinger, A Heisel, G von Bernuth, et al.
Zeitschrift Fur Kardiologie
|
February 20, 1999
[Reproducibility of the effectiveness of defibrillation for terminating induced ventricular fibrillation using intraoperatively measured defibrillation threshold energy in patients with implanted cardioverter-defibrillator]
J Jung, J Neuzner, E Himmrich, et al.
Journal of Pediatric Hematology/Oncology
|
July 1, 1997
The use of implantable venous access devices (IVADs) in children with hemophilia
J L Perkins, V A Johnson, J M Osip, et al.
The American Journal of Cardiology
|
March 25, 1999
Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter Low-Energy Endotak Trial
J Neuzner, A Liebrich, J Jung, et al.
The Journal of Pediatrics
|
October 1, 1984
Congenital pernicious anemia: report of seven patients, with studies of the extended family
M A Heisel, S E Siegel, R E Falk, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
September 9, 2018
Long-term symptom improvement and patient satisfaction after AV-node ablation vs. pulmonary vein isolation for symptomatic atrial fibrillation: results from the German Ablation Registry
Kristina Wasmer, M Hochadel, H Wieneke, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
June 28, 2000
Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors
S Arkin, F Blei, J Fetten, et al.
Blood
|
September 24, 2004
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B
Amy D Shapiro, Jorge Di Paola, Alice Cohen, et al.
Page
of 7